We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Baxter International Stock

Invest in or calculate the value of your shares in Baxter International or other pre-IPO companies through EquityZen's platform.

Get Started
View More Companies

Baxter International Stock

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people.

Invest NowSell Shares

About Baxter International Stock

Founded

1931

Headquarters

Deerfield, IL, US

Industries

Science and Engineering, Health Care, Biotechnology

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Baxter International Press Mentions

Stay in the know about the latest news on Baxter International

Connecting Yourself to "Value/s"

Forbes • Dec 06, 2019

Edwards Lifesciences Would Make Peter Drucker Smile

Forbes • Nov 29, 2019

A Canadian Citizen Held in Syrian Prisons is Set Free

New York Times • Aug 09, 2019

Facebook Board to Tighten Oversight, as Zuckerberg Keeps Control

Wall Streets Journal • Jul 24, 2019

Shutdown's Latest Victim: Hundreds Of Delayed Lifesaving Medical Devices

Forbes • Jan 24, 2019

Baxter International Management

Leadership team at Baxter International

Senior Manager, International Pricing & Tender Strategy

Richard Waygood

Corporate Vice President and Chief Financial Officer

James K. Saccaro

Locked Features

Join now and verify your accreditation status to gain access to:

  • Baxter International Current Valuation
  • Baxter International Stock Price
  • Baxter International Management
  • Available deals in Baxter International and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Baxter International Cap Table and Funding History by Share Class and Liquidity Preferences
    • Baxter International Revenue and Financials
    • Baxter International Highlights
    • Baxter International Business Model
    • Baxter International Risk Factors
  • Baxter International Research Report from SACRA Research
Join Now

Trading Baxter International Stock

How to invest in Baxter International stock?

Accredited investors can buy pre-IPO stock in companies like Baxter International through EquityZen funds. These investments are made available by existing Baxter International shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Baxter International stock?

Shareholders can sell their Baxter International stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Baxter International